Tilia Fiduciary Partners’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-201
Closed -$41.8K 300
2023
Q2
$41.8K Buy
201
+21
+12% +$4.07K 0.04% 235
2023
Q1
$35.6K Hold
180
0.03% 245
2022
Q4
$36.5K Hold
180
0.04% 227
2022
Q3
$32K Hold
180
0.03% 236
2022
Q2
$37K Hold
180
0.04% 236
2022
Q1
$41K Hold
180
0.03% 239
2021
Q4
$49K Buy
+180
New +$44.6K 0.04% 230

Other funds holding LH

Tilia Fiduciary Partners's LH Position: Q3 2023 in Review

Tilia Fiduciary Partners sold out of Labcorp (LH) in Q3 2023, closing a stake of 201 shares — an estimated $41.8K sold.

Tilia Fiduciary Partners first reported a position in LH in Q4 2021 and held it in 7 quarters. The position peaked at $49K in Q4 2021. 882 funds tracked by Wall St. Rank hold LH as of Q3 2023.

  • Tilia Fiduciary Partners reported no remaining Labcorp position as of Q3 2023 after selling out during the quarter.
  • Tilia Fiduciary Partners sold 201 Labcorp shares in Q3 2023, an estimated $41.8K.
  • Tilia Fiduciary Partners first reported a position in Labcorp in Q4 2021 and held it in 7 quarters.
  • Tilia Fiduciary Partners's Labcorp position peaked at $49K in Q4 2021.
  • 882 funds tracked by Wall St. Rank held Labcorp as of Q3 2023.

Based on Tilia Fiduciary Partners's 13F filing for Q3 2023, filed 10 Oct 2023.